{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:32:00Z","timestamp":1717115520422},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,30]]},"DOI":"10.7759\/cureus.61351","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:26:02Z","timestamp":1717064762000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Therapeutic Leukapheresis for Chronic Myeloid Leukemia Identified by Persistent Erection: A Case Report"],"prefix":"10.7759","author":[{"given":"Ryo","family":"Kamidani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokazu","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.ajts_160_21","article-title":"Effect of leukapheresis on pain reduction in leukemic priapism","volume":"16","author":"Noushad S","year":"2022","unstructured":"Noushad S, Sahoo D, Basavarajegowda A, Toora E, Paudel P. Effect of leukapheresis on pain reduction in leukemic priapism. Asian J Transfus Sci. 2022, 16:124-7. 10.4103\/ajts.ajts_160_21","journal-title":"Asian J Transfus Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21588","article-title":"Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis","volume":"33","author":"Cline A","year":"2018","unstructured":"Cline A, Jajosky R, Shikle J, Bollag R. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis. J Clin Apher. 2018, 33:396-400. 10.1002\/jca.21588","journal-title":"J Clin Apher"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21644","article-title":"Therapeutic white blood cell and platelet depletions using the spectra OPTIA system continuous mononuclear cell protocol","volume":"33","author":"Cates NC","year":"2018","unstructured":"Cates NC, Oakley DJ, Onwuemene OA. Therapeutic white blood cell and platelet depletions using the spectra OPTIA system continuous mononuclear cell protocol. J Clin Apher. 2018, 33:580-5. 10.1002\/jca.21644","journal-title":"J Clin Apher"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal JE","year":"1984","unstructured":"Sokal JE, Cox EB, Baccarani M, et al.. Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia. Blood. 1984, 63:789-99.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing committee for the collaborative CML prognostic factors project group","volume":"90","author":"Hasford J","year":"1998","unstructured":"Hasford J, Pfirrmann M, Hehlmann R, et al.. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing committee for the collaborative CML prognostic factors project group. J Natl Cancer Inst. 1998, 90:850-8. 10.1093\/jnci\/90.11.850","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-319038","article-title":"Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score","volume":"118","author":"Hasford J","year":"2011","unstructured":"Hasford J, Baccarani M, Hoffmann V, et al.. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score. Blood. 2011, 118:686-92. 10.1182\/blood-2010-12-319038","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.261","article-title":"Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia","volume":"30","author":"Pfirrmann M","year":"2016","unstructured":"Pfirrmann M, Baccarani M, Saussele S, et al.. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. Leukemia. 2016, 30:48-56. 10.1038\/leu.2015.261","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v92i3.10796","article-title":"Priapism in patients with chronic myeloid leukemia (CML): a systematic review","volume":"92","author":"Ali E","year":"2021","unstructured":"Ali E, Soliman A, De Sanctis V, Nussbaumer D, Yassin M. Priapism in patients with chronic myeloid leukemia (CML): a systematic review. Acta Biomed. 2021, 92:e2021193. 10.23750\/abm.v92i3.10796","journal-title":"Acta Biomed"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague DK","year":"2003","unstructured":"Montague DK, Jarow J, Broderick GA, et al.. American Urological Association guideline on the management of priapism. J Urol. 2003, 170:1318-24. 10.1097\/01.ju.0000087608.07371.ca","journal-title":"J Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21628","article-title":"Conservative management of priapism secondary to leukemia","volume":"51","author":"Castagnetti M","year":"2008","unstructured":"Castagnetti M, Sainati L, Giona F, Varotto S, Carli M, Rigamonti W. Conservative management of priapism secondary to leukemia. Pediatr Blood Cancer. 2008, 51:420-3. 10.1002\/pbc.21628","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1270754","article-title":"Hyperleukocytosis and leukostasis: management of a medical emergency","volume":"10","author":"Giammarco S","year":"2017","unstructured":"Giammarco S, Chiusolo P, Piccirillo N, et al.. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev Hematol. 2017, 10:147-54. 10.1080\/17474086.2017.1270754","journal-title":"Expert Rev Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000006367","article-title":"Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein","volume":"43","author":"Cukierman T","year":"2002","unstructured":"Cukierman T, Gatt ME, Libster D, Goldschmidt N, Matzner Y. Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein. Leuk Lymphoma. 2002, 43:1865-8. 10.1080\/1042819021000006367","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22038","article-title":"Safety and performance of the spectra Optia apheresis system for white blood cell depletion in patients with elevated white blood cell counts","volume":"38","author":"Lopert P","year":"2023","unstructured":"Lopert P, Abdelrahman S, Graybill CA, et al.. Safety and performance of the spectra Optia apheresis system for white blood cell depletion in patients with elevated white blood cell counts. J Clin Apher. 2023, 38:396-405. 10.1002\/jca.22038","journal-title":"J Clin Apher"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255358-successful-therapeutic-leukapheresis-for-chronic-myeloid-leukemia-identified-by-persistent-erection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:26:06Z","timestamp":1717064766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255358-successful-therapeutic-leukapheresis-for-chronic-myeloid-leukemia-identified-by-persistent-erection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.61351","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}